Frank Loescher, PhD, CEO Dermaliq, said, “we are pleased to welcome four highly respected members to our Scientific and Medical Advisory Board as we now advance three programs into the clinic: DLQ01 (Androgenetic Alopecia), DLQ02 (Psoriasis) and DLQ03 (Bacterial Skin and Soft Tissue Infectio...
To begin, these 8 stakeholders were asked if they were aware of any currently offered combined programs in either Canada or the USA. Of them, 2 were aware that other combined programs were offered. When asked, in general, if they felt a combined program was a good idea, all participants ...